Century Therapeutics, Inc. (IPSC) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts IPSC Hot Sheet
Join SI Premium – FREE
Century Therapeutics, Inc. (NASDAQ: IPSC) reported Q3 EPS of ($0.40), $0.01 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Century Therapeutics, Inc. (IPSC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Starts BillionToOne Inc (BLLN) at Buy
- Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance
- Global S&P Futures mixed to lower in premarket
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
